Molecular monitoring of response to imatinib (Glivec®) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission

詳細情報 詳細情報について

• CRID

  1361137044125835520

• NII論文ID

  30014036399

• DOI

  10.1038/sj.leu.2403033

• ISSN

  14765551

  08876924

  http://id.crossref.org/issn/08876924

• Web Site

  https://www.nature.com/articles/2403033.pdf

  https://www.nature.com/articles/2403033

• データソース種別

  • Crossref
  • CiNii Articles